CRISPR screening reveals targets to reprogram long... (ID 520908) - BioProject

Format

Choose Destination

Accession: PRJNA520908 ID: 520908

CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq] (house mouse)

See Genome Information for Mus musculus

Navigate Up

Navigate Across

4 additional projects are components of the CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy..

CD8+ T cells can be reprogrammed for better persistence and robust effector function in TME. More...

Accession	PRJNA520908; GEO: GSE126070
Data Type	Epigenomics
Scope	Multiisolate
Organism	Mus musculus[Taxonomy ID: 10090] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus; Mus musculus
Publications	Wei J et al., "Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.", Nature, 2019 Dec;576(7787):471-476
Submission	Registration date: 4-Feb-2019 Immunology, St Jude Children's Research Hospital
Relevance	Model Organism

Project Data:

Parameter	Value
Data volume, Supplementary Mbytes	716

Parameter	Value
Data volume, Gbases	274
Data volume, Mbytes	65535

Supplemental Content

CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells f...
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]

BioProject
Homo sapiens
Homo sapiens
Homo sapiens Exome

BioProject
Pseudomonas Sp.
Pseudomonas Sp.
Pseudomonas Sp.JV241A

BioProject
Corynebacterium pseudotuberculosis strain:E14
Corynebacterium pseudotuberculosis strain:E14
Corynebacterium pseudotuberculosis E14 Genome sequencing and assembly

BioProject

Your browsing activity is empty.

Activity recording is turned off.